Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer’s disease and vascular dementia

Thitipon Yaowaluk, Vorapun Senanarong, Chanin Limwongse, Rasda Boonprasert, Pornpimol Kijsanayotin
  • Pharmacogenomics and Personalized Medicine, September 2019, Taylor & Francis
  • DOI: 10.2147/pgpm.s211259

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/pgpm.s211259

The following have contributed to this page: Vorapun Senanarong and Dr Pornpimol Kijsanayotin